(EXHE) iShares Pfandbriefe (DE) - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE0002635265

Corporate Bonds, Fixed Income, Euro Securities

Description: EXHE iShares Pfandbriefe (DE)

The iShares Pfandbriefe UCITS ETF (DE) is a German-originated ETF that tracks the Morningstar EZN Corp Bd GR EUR index, providing investors with exposure to EUR-denominated corporate bonds. This ETF is listed on the XETRA exchange under the ticker symbol EXHE.

As an ETF categorized under EUR Corporate Bond, it invests in a diversified portfolio of corporate bonds denominated in Euros, offering a relatively stable source of returns in a low-interest-rate environment. The funds underlying assets are likely comprised of high-quality corporate bonds with varying maturities, providing a yield advantage over traditional fixed-income investments.

Analyzing the ETFs recent price action, we observe a stable trend, with the last price recorded at 96.82. The short-term moving averages (SMA20: 96.89, SMA50: 96.78) indicate a slight consolidation phase, while the longer-term SMA200 at 95.75 suggests a positive upward trend. The Average True Range (ATR) of 0.20, equivalent to 0.21%, indicates relatively low volatility, making it an attractive option for risk-averse investors.

With Assets Under Management (AUM) of 494.41M EUR, the ETF has achieved a reasonable scale, which can contribute to lower expense ratios and improved liquidity. As the fund continues to attract investors seeking exposure to EUR corporate bonds, we can expect the AUM to grow, potentially leading to improved tracking efficiency.

Forecasting the ETFs future performance using historical technical and fundamental data, we anticipate a steady trend, potentially reaching a new 52-week high above 97.01, driven by the ongoing demand for high-quality corporate bonds in the Eurozone. However, any significant changes in interest rates or credit spreads may impact the ETFs performance, and investors should closely monitor these factors. Based on the current SMA20 and SMA50, a potential target price could be around 97.20, representing a 0.4% increase from the current level.

Additional Sources for EXHE ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EXHE ETF Overview

Market Cap in USD 578m
Category EUR Corporate Bond
IPO / Inception 2004-12-02

EXHE ETF Ratings

Growth Rating -5.58
Fundamental -
Dividend Rating 57.6
Rel. Strength 9.3
Analysts -
Fair Price Momentum 91.54 EUR
Fair Price DCF -

EXHE Dividends

Dividend Yield 12m 1.50%
Yield on Cost 5y 1.40%
Annual Growth 5y 24.83%
Payout Consistency 84.7%
Payout Ratio %

EXHE Growth Ratios

Growth Correlation 3m 46.2%
Growth Correlation 12m 90%
Growth Correlation 5y -55.1%
CAGR 5y -1.32%
CAGR/Max DD 5y -0.08
Sharpe Ratio 12m 0.55
Alpha -0.12
Beta -0.014
Volatility 2.25%
Current Volume 1k
Average Volume 20d 0.8k
Stop Loss 93.9 (-3%)
What is the price of EXHE shares?
As of July 16, 2025, the stock is trading at EUR 96.82 with a total of 1,025 shares traded.
Over the past week, the price has changed by -0.05%, over one month by -0.12%, over three months by +0.35% and over the past year by +4.34%.
Is iShares Pfandbriefe (DE) a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares Pfandbriefe (DE) is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -5.58 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXHE is around 91.54 EUR . This means that EXHE is currently overvalued and has a potential downside of -5.45%.
Is EXHE a buy, sell or hold?
iShares Pfandbriefe (DE) has no consensus analysts rating.
What are the forecasts for EXHE share price target?
According to our own proprietary Forecast Model, EXHE iShares Pfandbriefe (DE) will be worth about 98.9 in July 2026. The stock is currently trading at 96.82. This means that the stock has a potential upside of +2.12%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 98.9 2.1%